ACR. https://www.acr.org/Quality-Safety/Resources/LIRADS. Accessed July 8, 2021

Sherman M. The radiological diagnosis of hepatocellular carcinoma. Am J Gastroenterol. 2010;105(3):610–2. https://doi.org/10.1038/ajg.2009.663.

Article  PubMed  Google Scholar 

Yamashita Y, Komohara Y, Takahashi M, Uchida M, Hayabuchi M, Shimizu T, et al. Abdominal helical CT: evaluation of optimal doses of intravenous contrast material—a prospective randomized study. Radiology. 2000;216(3):718–23. https://doi.org/10.1148/radiology.216.3.r00se26718.

Article  CAS  PubMed  Google Scholar 

Awai K, Inoue M, Yagyu Y, Watanabe M, Sano T, Nin S, et al. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT. Radiology. 2004;233(3):682–8. https://doi.org/10.1148/radiol.2333031617.

Article  PubMed  Google Scholar 

Koiwahara G, Tsuda T, Matsuda M, Hirata M, Tanaka H, Hyodo T, et al. Different enhancement of the hepatic parenchyma in dynamic CT for patients with normal liver and chronic liver diseases and with the dose of contrast medium based on body surface area. Jpn J Radiol. 2015;33(4):194–200. https://doi.org/10.1007/s11604-015-0398-1.

Article  CAS  PubMed  Google Scholar 

Vignaux O, Legmann P, Coste J, Hoeffel C, Bonnin A. Cirrhotic liver enhancement on dual-phase helical CT: comparison with noncirrhotic livers in 146 patients. AJR Am J Roentgenol. 1999;173(5):1193–7. https://doi.org/10.2214/ajr.173.5.10541087.

Article  CAS  PubMed  Google Scholar 

Inokuchi Y, Uematsu M, Takashina T. Diagnostic accuracy of the attenuation value in abdominal contrast enhanced dynamic multi-detector-row computed tomography for esophageal varices in patients with liver cirrhosis. Eur J Radiol Open. 2021;23(8): 100347. https://doi.org/10.1016/j.ejro.2021.100347.

Article  Google Scholar 

Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1–85.

CAS  PubMed  Google Scholar 

Johnson PJ, Belhane S, Kagebayashi C, Satomura S, Teng M, Reeves H, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33:550–8. https://doi.org/10.1200/JCO.2014.57.9151.

Article  PubMed  Google Scholar 

Hiraoka A, Kumada T, Kudo M, Hirooka M, Tsuji K, Itobayashi E, et al. Albumin-Bilirubin (ALBI) grade as part of the evidence-based clinical practice guideline for HCC of the Japan Society of Hepatology: a comparison with the liver damage and child-pugh classifications. Liver Cancer. 2017;6(3):204–15. https://doi.org/10.1159/000452846.

Article  PubMed  PubMed Central  Google Scholar 

Fagenson AM, Gleeson EM, Pitt HA, Lau KN. Albumin-bilirubin score vs model for end-stage liver disease in predicting post-hepatectomy outcomes. J Am Coll Surg. 2020;230:637–45. https://doi.org/10.1016/j.jamcollsurg.2019.12.007.

Article  PubMed  Google Scholar 

Wang YY, Zhong JH, Su ZY, Huang JF, Lu SD, Xiang BD, et al. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Br J Surg. 2016;103:725–34. https://doi.org/10.1002/bjs.10095.

Article  CAS  PubMed  Google Scholar 

Tai K, Kuramitsu K, Kido M, Tanaka M, Komatsu S, Awazu M, et al. Impact of albumin-bilirubin score on short- and long-term survival after living- donor liver transplantation: a retrospective study. Transpl Proc. 2020;52:910–9. https://doi.org/10.1016/j.transproceed.2020.01.020.

Article  CAS  Google Scholar 

Kornberg A, Witt U, Schernhammer M, Kornberg J, Muller K, Friess H, et al. The role of preoperative albumin-bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma. J Surg Oncol. 2019;120:1126–36. https://doi.org/10.1002/jso.25721.

Article  CAS  PubMed  Google Scholar 

An C, Li X, Yu X, Cheng Z, Han Z, Liu F, et al. Nomogram based on albumin-bilirubin grade to predict outcome of the patients with hepatitis C virus-related hepatocellular carcinoma after microwave ablation. Cancer Biol Med. 2019;16:797–810. https://doi.org/10.20892/j.issn.2095-3941.2018.0486.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Antkowiak M, Gabr A, Das A, Ali R, Kulik L, Ganger D, et al. Prognostic role of albumin, bilirubin, and ALBI scores: analysis of 1000 patients with hepatocellular carcinoma undergoing radioembolization. Cancers (Basel). 2019;11(6):879. https://doi.org/10.3390/cancers11060879.

Article  CAS  PubMed  Google Scholar 

Mohammadi H, Abuodeh Y, Jin W, Frakes J, Friedman M, Biebel B, et al. Using the albumin-bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinoma. J Gastrointest Oncol. 2018;9:840–6. https://doi.org/10.21037/jgo.2018.05.14.

Article  PubMed  PubMed Central  Google Scholar 

Tada T, Kumada T, Toyoda H, Tsuji K, Hiraoka A, Michitaka K, et al. Impact of albumin- bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: an analysis using time- dependent receiver operating characteristic. J Gastroenterol Hepatol. 2019;34:1066–73. https://doi.org/10.1111/jgh.14564.

Article  CAS  PubMed  Google Scholar 

Ueshima K, Nishida N, Hagiwara S, Aoki T, Minami T, Chishina H, et al. Impact of baseline ALBI grade on the outcomes of hepatocellular carcinoma patients treated with lenvatinib: a multicenter study. Cancers (Basel). 2019;11(7):952. https://doi.org/10.3390/cancers11070952.

Article  CAS  PubMed  Google Scholar 

Bloom S, Kemp W, Lubel J. Portal hypertension: pathophysiology, diagnosis and management. Intern Med J. 2015;45:16–26. https://doi.org/10.1111/imj.12590.

Article  CAS  PubMed  Google Scholar 

Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology. 2006;43:121–31. https://doi.org/10.1002/hep.20993.

Article  CAS  Google Scholar 

Shojaie L, Iorga A, Dara L. Cell death in liver diseases: a review. Int J Mol Sci. 2020;21(24):9682. https://doi.org/10.3390/ijms21249682.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ogasawara S, Chiba T, Ooka Y, Suzuki E, Kanogawa N, Saito T, et al. Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma. Invest New Drugs. 2015;33:1257–62. https://doi.org/10.1007/s10637-015-0292-9.

Article  CAS  PubMed  Google Scholar 

Fujita K, Nomura T, Morishita A, Oura K, Yoneyama H, Kobara H, et al. Albumin-bilirubin score differentiates liver fibrosis stage and hepatocellular carcinoma incidence in chronic hepatitis b virus infection: a retrospective cohort study. Am J Trop Med Hyg. 2019;101:220–5. https://doi.org/10.4269/ajtmh.19-0129.

Article  PubMed  PubMed Central  Google Scholar 

Fujita K, Oura K, Yoneyama H, Shi T, Takuma K, Nakahara M, Tadokoro T, Nomura T, Morishita A, Tsutsui K, Himoto T, Masaki T. Albumin-bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C. Hepatol Res. 2019;49:731–42. https://doi.org/10.1111/hepr.13333.

Article  CAS  PubMed  PubMed Central  Google Scholar